OS

TAGRISSO® (osimertinib) demonstrated overwhelming efficacy benefit for patients with unresectable, Stage III EGFR-mutated lung cancer in LAURA Phase III trial

Retrieved on: 
Monday, February 19, 2024
Oncology, FDA, Health, Clinical Trials, Pharmaceutical, Biotechnology, NSCLC, Fever, Progression-free survival, PFS, AstraZeneca, Heart, Periodic breathing, QT interval, MD, Chemoradiotherapy, Cough, Pemetrexed, Winship Cancer Institute, QT, OS, Electrolyte, Cardiomyopathy, Lung cancer, Safety, Emory University, CRT, LAURA, ILD, Patient, LVEF, Brain, Pharmaceutical industry

In addition, TAGRISSO plus chemotherapy was recently approved in the US based on the FLAURA2 Phase III trial.

Key Points: 
  • In addition, TAGRISSO plus chemotherapy was recently approved in the US based on the FLAURA2 Phase III trial.
  • Interstitial lung disease (ILD)/pneumonitis occurred in 4% of the 1813 TAGRISSO-treated patients; 0.4% of cases were fatal.
  • TAGRISSO is the only targeted therapy to improve patient outcomes in both early-stage disease in the ADAURA Phase III trial and late-stage disease in the FLAURA Phase III trial and FLAURA2 Phase III trial .
  • AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.

Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Advanced Nonsquamous Non-Small Cell Lung Cancer

Retrieved on: 
Monday, February 19, 2024
Oncology, Health, FDA, Clinical Trials, Pharmaceutical, Biotechnology, NSCLC, Breast cancer, Progression-free survival, PFS, AstraZeneca, Docetaxel, Doctor of Philosophy, MD, News, Food, BLA, PDUFA, Lung, Daiichi Sankyo, ADC, OS, IHC, HER2, Lung cancer, DXD, Patient, Congress, Pharmaceutical industry

Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the U.S. for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) who have received prior systemic therapy.

Key Points: 
  • Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the U.S. for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) who have received prior systemic therapy.
  • Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) being jointly developed by Daiichi Sankyo and AstraZeneca.
  • In patients with nonsquamous NSCLC, datopotamab deruxtecan showed a clinically meaningful PFS benefit and a numerically favorable OS trend.
  • Additional regulatory submissions for datopotamab deruxtecan in lung and breast cancer are underway globally.

IGEL Names Donny Harder Vice President, Global Revenue Operations

Retrieved on: 
Thursday, March 7, 2024
Acquisition, SAN, IGEL, Marketing, Growth, HP, OS, St. Olaf College, Automation, Management

SAN FRANCISCO, March 7, 2024 /PRNewswire/ -- IGEL, provider of the secure endpoint OS for now and next, today announced the addition of Donny Harder as Vice President, Global Revenue Operations. An experienced sales and marketing operational leader, Harder brings deep experience in building high performing revenue operations teams for the enhanced sales process optimization that accelerates customer acquisition.

Key Points: 
  • SAN FRANCISCO, March 7, 2024 /PRNewswire/ -- IGEL , provider of the secure endpoint OS for now and next, today announced the addition of Donny Harder as Vice President, Global Revenue Operations.
  • An experienced sales and marketing operational leader, Harder brings deep experience in building high performing revenue operations teams for the enhanced sales process optimization that accelerates customer acquisition.
  • "As IGEL continues to execute its rapid global expansion strategy, executing with operational excellence is a critical element to our success," said Klaus Oestermann, CEO, IGEL.
  • Donny Harder is a proven revenue operations leader who is all too familiar with building out high-functioning Revenue Operations organizations from scratch to support rapidly growing sales teams.

Media Fragmentation Problems Solved with CMI Media Group Advancements to Empower Operating System

Retrieved on: 
Wednesday, March 6, 2024
Insight, Caregiver, EVP, AI, AMO, Investment, Health, Empower, OS, Software as a service, CRM, Automation, Patient, Martech, WPP, Workflow

PHILADELPHIA, March 6, 2024 /PRNewswire-PRWeb/ -- Strategic media healthcare agency CMI Media Group, a WPP company (NYSE: WPP), today announces the evolution of its Empower ™ operating system, a technology solution that unifies industry leading tools and features into a SaaS-enabled, modular, agile, and innovative framework. It is the first of its kind, award-winning operating system, built specifically for the health marketplace, and designed to unlock the power of data-driven media strategy and seamless execution within a transparent and collaborative interface. The operating system is built on 30+ years of leadership in the development of award-winning omnichannel solutions and services, and pairs them with newly developed applications that continue to drive better engagement and outcomes for health and life science brands.

Key Points: 
  • Strategic media healthcare agency CMI Media Group, a WPP company (NYSE: WPP), today announces the evolution of its Empower ™ operating system, a technology solution that unifies industry leading tools and features into a SaaS-enabled, modular, agile, and innovative framework.
  • PHILADELPHIA, March 6, 2024 /PRNewswire-PRWeb/ -- Strategic media healthcare agency CMI Media Group, a WPP company (NYSE: WPP), today announces the evolution of its Empower ™ operating system, a technology solution that unifies industry leading tools and features into a SaaS-enabled, modular, agile, and innovative framework.
  • Empower OS is the first integrated HCP/DTC operating system that allows true connectivity and planning between audiences from insights to activation and automation.
  • With this secure, agile, and scalable solution, CMI Media Group is leveraging the world's most innovative technology and data.

CMF by Nothing Debuts Neckband Pro and Buds

Retrieved on: 
Tuesday, March 5, 2024
Paul Dirac, Engineering, Diaphragm, USD, Weather, IST, Noise, IP55, Eye, Life, OS, Crystal, EQ, AMOLED, Smartphone, Perspiration, ANC, MP, Environment, Music, GBP, CMF, Mah, Cassette tape

LONDON, March 5, 2024 /PRNewswire/ -- CMF, a sub-brand of Nothing, has today announced the launch of Buds and Neckband Pro. In less than one year, CMF by Nothing has proven that great design and high product quality are not limited to the premium price point category. Its 2024 initial products bring forth Neckband Pro, the first 50 dB Hybrid ANC device in this category and Buds, which deliver best-in-class ANC across the price segment.

Key Points: 
  • LONDON, March 5, 2024 /PRNewswire/ -- CMF, a sub-brand of Nothing, has today announced the launch of Buds and Neckband Pro.
  • Its 2024 initial products bring forth Neckband Pro, the first 50 dB Hybrid ANC device in this category and Buds, which deliver best-in-class ANC across the price segment.
  • Today, we are excited to launch Buds and Neckband Pro, and even more excited about everything that's to come."
  • Neckband Pro is equipped with an advanced chipset and five HD mics to deliver top noise cancellation of up to 50 dB.

Nothing Introduces Phone (2a)

Retrieved on: 
Tuesday, March 5, 2024
Perplexity, Engineering, Love, Light, Algorithm, Milk, AI, Intelligence, Temperature, Noise, Programmer, Life, RAM, MediaTek, OS, RAW, Risk, Carbon, Hertz, Third party, AMOLED, City, Smartphone, TSMC, ANC, Charge density, MP, Mah, NFC, Longevity, Brain, CMF, Software, Partnership, Mobile phone

LONDON, March 5, 2024 /PRNewswire/ -- Nothing today announced Phone (2a), its highly anticipated new smartphone offering. Phone (2a) is here to provide the optimal daily smartphone experience, doubling down on core user needs with all of Nothing's expertise, engineering and craftsmanship. A device for people who love to explore new innovations and designs but also know what they want (and don't want) from their smartphone. Including a powerfully unique processor, an exceptional 50 MP dual rear camera, an extra bright flexible AMOLED display, and an intuitive OS that delivers a fast and smooth experience with every interaction.

Key Points: 
  • Built on TSMC's latest second-generation 4nm process technology, Phone (2a) effortlessly powers through any task with unparalleled power efficiency and blazing speed.
  • For landing the perfect selfies anytime, anywhere, Phone (2a) has an exceptional 32 MP front camera that uses the same sensor as Phone (2), which has 27% more light sensitivity versus Phone (1) and enables more details to come through.
  • On the back of the phone, Phone (2a) reimagines the iconic Glyph Interface.
  • Perplexity is a beautifully designed answer engine and Nothing Phone (2a) is a beautifully designed device, and we are excited to bring Perplexity Pro to Phone (2a) users."

CMF by Nothing Debuts Neckband Pro and Buds

Retrieved on: 
Tuesday, March 5, 2024
Paul Dirac, Engineering, Diaphragm, USD, Weather, IST, Noise, IP55, Eye, Life, OS, Crystal, EQ, AMOLED, Smartphone, Perspiration, ANC, MP, Environment, Music, GBP, CMF, Mah, Cassette tape

LONDON, March 5, 2024 /PRNewswire/ -- CMF, a sub-brand of Nothing, has today announced the launch of Buds and Neckband Pro. In less than one year, CMF by Nothing has proven that great design and high product quality are not limited to the premium price point category. Its 2024 initial products bring forth Neckband Pro, the first 50 dB Hybrid ANC device in this category and Buds, which deliver best-in-class ANC across the price segment.

Key Points: 
  • LONDON, March 5, 2024 /PRNewswire/ -- CMF, a sub-brand of Nothing, has today announced the launch of Buds and Neckband Pro.
  • Its 2024 initial products bring forth Neckband Pro, the first 50 dB Hybrid ANC device in this category and Buds, which deliver best-in-class ANC across the price segment.
  • Today, we are excited to launch Buds and Neckband Pro, and even more excited about everything that's to come."
  • Neckband Pro is equipped with an advanced chipset and five HD mics to deliver top noise cancellation of up to 50 dB.

Nothing Introduces Phone (2a)

Retrieved on: 
Tuesday, March 5, 2024
Perplexity, Engineering, Love, Light, Algorithm, Milk, AI, Intelligence, Temperature, Noise, Programmer, Life, RAM, MediaTek, OS, RAW, Risk, Carbon, Hertz, Third party, AMOLED, City, Smartphone, TSMC, ANC, Charge density, MP, Mah, NFC, Longevity, Brain, CMF, Software, Partnership, Mobile phone

LONDON, March 5, 2024 /PRNewswire/ -- Nothing today announced Phone (2a), its highly anticipated new smartphone offering. Phone (2a) is here to provide the optimal daily smartphone experience, doubling down on core user needs with all of Nothing's expertise, engineering and craftsmanship. A device for people who love to explore new innovations and designs but also know what they want (and don't want) from their smartphone. Including a powerfully unique processor, an exceptional 50 MP dual rear camera, an extra bright flexible AMOLED display, and an intuitive OS that delivers a fast and smooth experience with every interaction.

Key Points: 
  • Built on TSMC's latest second-generation 4nm process technology, Phone (2a) effortlessly powers through any task with unparalleled power efficiency and blazing speed.
  • For landing the perfect selfies anytime, anywhere, Phone (2a) has an exceptional 32 MP front camera that uses the same sensor as Phone (2), which has 27% more light sensitivity versus Phone (1) and enables more details to come through.
  • On the back of the phone, Phone (2a) reimagines the iconic Glyph Interface.
  • Perplexity is a beautifully designed answer engine and Nothing Phone (2a) is a beautifully designed device, and we are excited to bring Perplexity Pro to Phone (2a) users."

Humane Announces Strategic Partnership with SoftBank to Transform AI Experience in Japan

Retrieved on: 
Wednesday, February 28, 2024
Cloud, SoftBank Group, Mobile, Internet of things, Growth, OS, Mobile World Congress, Cosmos, Ecosystem, Telco, Congress, Telecommunications, Partnership, Medical device

BARCELONA, Spain, Feb. 28, 2024 /PRNewswire/ -- In a further announcement at Mobile World Congress, Humane Inc today revealed plans for a Telco partnership with SoftBank Corp.(SoftBank) for the Humane Ai Pin, the first stand-alone Ai device and proprietary Ai-driven OS, CosmOS.

Key Points: 
  • BARCELONA, Spain, Feb. 28, 2024 /PRNewswire/ -- In a further announcement at Mobile World Congress, Humane Inc today revealed plans for a Telco partnership with SoftBank Corp.(SoftBank) for the Humane Ai Pin, the first stand-alone Ai device and proprietary Ai-driven OS, CosmOS.
  • This partnership, as part of a strategic investment opportunity, will see SoftBank become the exclusive telecom provider for Ai Pin in Japan, leveraging SoftBank's top-class services and compelling customer touchpoints to bring Ai Pin to a new market.
  • SoftBank and Humane will also explore bringing CosmOS to other mobile devices and be working together on an app-less ecosystem of third-party services and AI-driven user experiences in Japan.
  • Imran Chaudhri and Bethany Bongiorno, co-founders of Humane: "Partnering with SoftBank allows us to bring our vision of more intuitive and seamless AI experiences directly to Japanese consumers.

HONOR Illuminates the Future of AI in Smart Devices at MWC

Retrieved on: 
Tuesday, February 27, 2024
UI, IUI, GSMA, Smart device, MWC, Growth, Security, OS, Accountability, Telstra, Qualcomm, MCX, History, Controllability, Inmarsat, Fairness, Smartphone, Ecosystem, Privacy, Personal computer, Justice, Research, The Magic Portal, Medical device

BARCELONA, Spain, Feb. 27, 2024 /PRNewswire/ -- At MWC Barcelona 2024, George Zhao, CEO of HONOR Device Co., Ltd., took the stage with industry leaders for a thought-provoking panel discussion. The session, titled "Putting Humans First in AI Development: Key Considerations for Creating AI for Smart Devices," also featured John Hoffman, CEO of GSMA Ltd., and Alex Katouzian, Group GM of MCX, Qualcomm Technologies, Inc.. Together, they underscored the significance of crafting AI devices that champion an intuitive, human-centric experience while ensuring user privacy.

Key Points: 
  • Together, they underscored the significance of crafting AI devices that champion an intuitive, human-centric experience while ensuring user privacy.
  • HONOR will advance our AI strategy by integrating it across MagicOS and all HONOR devices, ensuring a human-centric experience that delights our users with every interaction."
  • HONOR's expertise in on-device AI is demonstrated through the launch of MagicOS 8.0 at MWC, which fully integrated platform-level AI and the industry's first intent-based user interface (IUI).
  • "Platform-level AI and LLMs enable HONOR to seamlessly blend AI devices such as AI PCs and AI smartphones into users' daily lives, understanding their intent and anticipating their needs," Zhao shared.